Short answer
Compass Therapeutics, Inc. (CMPX) filed an 8-K current report with the SEC on May 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Filing contains only signature and Inline XBRL exhibit references, without substantive fiscal-year 2026 results.
Compass Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Filing contains only signature and Inline XBRL exhibit references, without substantive fiscal-year 2026 results
- Results details unavailable in the provided text; investors should review the referenced earnings exhibit for financial information
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Compass Therapeutics, Inc. 8-K filings
Get the next CMPX 8-K as it lands
Follow CMPX for push alerts, or ask the research agent what this filing means.